Alzheimer’s Research UK starts AI-based drug hunt with ExscientiaMedical charity Alzheimer’s Research UK has teamed up with artificial intelligence specialist Exscientia to find new drug treatments Share XAlzheimer’s Research UK starts AI-based drug hunt with Exscientiahttps://pharmaphorum.com/news/alzheimers-research-uk-starts-ai-based-drug-hunt-with-exscientia/
AI drug discovery biotech AbCellera eyes record IPOAbCellera Biologics has been in the spotlight since coming up with Eli Lilly’s COVID-19 antibody drug bamlanivimab, and Share XAI drug discovery biotech AbCellera eyes record IPOhttps://pharmaphorum.com/news/ai-drug-discovery-biotech-abcellera-eyes-record-ipo/
How the rare disease community has developed fertile ground for progressAmanda Barrell explores how a perfect storm of changing economics, advances in technology, and the increasing volume of Share XHow the rare disease community has developed fertile ground for progresshttps://pharmaphorum.com/views-analysis-patients/how-the-community-developed-fertile-ground-for-progress-in-rare-disease-drug-development/
BioNTech, InstaDeep plan joint lab for AI researchBioNTech may be deeply ensconced in the latter stages of its bid to bring a COVID-19 vaccine to Share XBioNTech, InstaDeep plan joint lab for AI researchhttps://pharmaphorum.com/news/biontech-instadeep-plan-joint-lab-for-ai-research/
BMS joins forces with insitro to develop neurodegenerative treatmentsinsitro has landed another big biopharma partnership, signing a five-year collaboration with Bristol Myers Sqibb to develop therapies Share XBMS joins forces with insitro to develop neurodegenerative treatmentshttps://pharmaphorum.com/news/bms-joins-forces-with-insitro-to-develop-neurodegenerative-treatments/
BERG taps supercomputer to speed AI discovery of COVID-19 drugsUS artificial intelligence company BERG has agreed a deal to access a federal supercomputer to help it hunt Share XBERG taps supercomputer to speed AI discovery of COVID-19 drugshttps://pharmaphorum.com/news/berg-taps-supercomputer-to-speed-ai-discovery-of-covid-19-drugs/
AI drug discovery firm Exscientia gets $60M cash injectionUK artificial intelligence specialist Exscientia has topped up its coffers with a $60 million Series C funding round Share XAI drug discovery firm Exscientia gets $60M cash injectionhttps://pharmaphorum.com/news/ai-drug-discovery-firm-exscientia-gets-60m-cash-injection/
Home PCs recruited to hunt down COVID-19 therapiesA well-established project that taps into spare processing power from home computers and consoles to find new drugs Share XHome PCs recruited to hunt down COVID-19 therapieshttps://pharmaphorum.com/news/home-pcs-recruited-to-hunt-down-covid-19-therapies/
Some pharmas acting like “toilet roll profiteers” on COVID-19, says clinicianA leading UK scientist says some drugmakers are acting like “supermarket hoarders” as coronavirus escalates, failing to share Share XSome pharmas acting like “toilet roll profiteers” on COVID-19, says clinicianhttps://pharmaphorum.com/news/some-pharmas-acting-like-toilet-roll-profiteers-on-covid-19-says-clinician/
